Literature DB >> 25347734

The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.

A Deutzmann1, M Ganz1, F Schönenberger1, J Vervoorts2, F Kappes2, E Ferrando-May1.   

Abstract

DNA replication stress is a major source of DNA strand breaks and genomic instability, and a hallmark of precancerous lesions. In these hyperproliferative tissues, activation of the DNA damage response results in apoptosis or senescence preventing or delaying their development to full malignancy. In cells, in which this antitumor barrier is disabled by mutations (for example, in p53), viability and further uncontrolled proliferation depend on factors that help to cope with replication-associated DNA damage. Replication problems preferentially arise in chromatin regions harboring complex DNA structures. DEK is a unique chromatin architectural factor which binds to non-B-form DNA structures, such as cruciform DNA or four-way junctions. It regulates DNA topology and chromatin organization, and is essential for the maintenance of heterochromatin integrity. Since its isolation as part of an oncogenic fusion in a subtype of AML, DEK has been consistently associated with tumor progression and chemoresistance. How DEK promotes cancer, however, is poorly understood. Here we show that DEK facilitates cellular proliferation under conditions of DNA replication stress by promoting replication fork progression. DEK also protects from the transmission of DNA damage to the daughter cell generation. We propose that DEK counteracts replication stress and ensures proliferative advantage by resolving problematic DNA and/or chromatin structures at the replication fork.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25347734     DOI: 10.1038/onc.2014.346

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Structure-specific binding of the proto-oncogene protein DEK to DNA.

Authors:  Tanja Waldmann; Martina Baack; Nicole Richter; Claudia Gruss
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

2.  Thresholds of replication stress signaling in cancer development and treatment.

Authors:  Jiri Bartek; Martin Mistrik; Jirina Bartkova
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

3.  Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors.

Authors:  Matilde Murga; Stefano Campaner; Andres J Lopez-Contreras; Luis I Toledo; Rebeca Soria; Maria F Montaña; Luana D' Artista; Thomas Schleker; Carmen Guerra; Elena Garcia; Mariano Barbacid; Manuel Hidalgo; Bruno Amati; Oscar Fernandez-Capetillo
Journal:  Nat Struct Mol Biol       Date:  2011-11-27       Impact factor: 15.369

4.  Spontaneous slow replication fork progression elicits mitosis alterations in homologous recombination-deficient mammalian cells.

Authors:  Therese Wilhelm; Indiana Magdalou; Aurélia Barascu; Hervé Técher; Michelle Debatisse; Bernard S Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-17       Impact factor: 11.205

5.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.

Authors:  Eva Petermann; Manuel Luís Orta; Natalia Issaeva; Niklas Schultz; Thomas Helleday
Journal:  Mol Cell       Date:  2010-02-26       Impact factor: 17.970

7.  Fanconi anemia proteins stabilize replication forks.

Authors:  Lily Chien Wang; Stacie Stone; Maureen Elizabeth Hoatlin; Jean Gautier
Journal:  DNA Repair (Amst)       Date:  2008-09-25

8.  DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Authors:  Trisha M Wise-Draper; Richard J Morreale; Teresa A Morris; Rachael A Mintz-Cole; Elizabeth E Hoskins; Scott J Balsitis; Nader Husseinzadeh; David P Witte; Kathryn A Wikenheiser-Brokamp; Paul F Lambert; Susanne I Wells
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

9.  Melanoma proliferation and chemoresistance controlled by the DEK oncogene.

Authors:  Michael S Khodadoust; Monique Verhaegen; Ferdinand Kappes; Erica Riveiro-Falkenbach; Juan C Cigudosa; David S L Kim; Arul M Chinnaiyan; David M Markovitz; María S Soengas
Journal:  Cancer Res       Date:  2009-08-15       Impact factor: 12.701

10.  The human DEK oncogene regulates DNA damage response signaling and repair.

Authors:  Gina M Kavanaugh; Trisha M Wise-Draper; Richard J Morreale; Monique A Morrison; Boris Gole; Sandy Schwemberger; Elisia D Tichy; Lu Lu; George F Babcock; James M Wells; Rachid Drissi; John J Bissler; Peter J Stambrook; Paul R Andreassen; Lisa Wiesmüller; Susanne I Wells
Journal:  Nucleic Acids Res       Date:  2011-06-07       Impact factor: 16.971

View more
  15 in total

1.  The nuclear DEK interactome supports multi-functionality.

Authors:  Eric A Smith; Eric F Krumpelbeck; Anil G Jegga; Malte Prell; Marie M Matrka; Ferdinand Kappes; Kenneth D Greis; Abdullah M Ali; Amom R Meetei; Susanne I Wells
Journal:  Proteins       Date:  2017-11-11

Review 2.  Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place.

Authors:  Panagiotis Kotsantis; Eva Petermann; Simon J Boulton
Journal:  Cancer Discov       Date:  2018-04-13       Impact factor: 39.397

3.  DEK over-expression promotes mitotic defects and micronucleus formation.

Authors:  Marie C Matrka; Robert F Hennigan; Ferdinand Kappes; Monica L DeLay; Paul F Lambert; Bruce J Aronow; Susanne I Wells
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

4.  TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.

Authors:  Sounak Gupta; Sarah H Johnson; George Vasmatzis; Binu Porath; Jeannette G Rustin; Priya Rao; Brian A Costello; Bradley C Leibovich; R Houston Thompson; John C Cheville; William R Sukov
Journal:  Mod Pathol       Date:  2017-03-24       Impact factor: 7.842

5.  Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors.

Authors:  Juana Serrano-Lopez; Kalpana Nattamai; Nicholas A Pease; Miranda S Shephard; Ashley M Wellendorf; Mathieu Sertorio; Eric A Smith; Hartmut Geiger; Susanne I Wells; Jose A Cancelas; Lisa M Privette Vinnedge
Journal:  Exp Hematol       Date:  2017-12-27       Impact factor: 3.084

Review 6.  Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer.

Authors:  Nicholas A Pease; Trisha Wise-Draper; Lisa Privette Vinnedge
Journal:  J Oncol       Date:  2015-09-06       Impact factor: 4.375

7.  The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.

Authors:  Yanan Zhang; Jie Liu; Shibin Wang; Xiaoli Luo; Yang Li; Zhaohui Lv; Jie Zhu; Jing Lin; Lihua Ding; Qinong Ye
Journal:  Oncotarget       Date:  2016-04-26

8.  DEK is required for homologous recombination repair of DNA breaks.

Authors:  Eric A Smith; Boris Gole; Nicholas A Willis; Rebeca Soria; Linda M Starnes; Eric F Krumpelbeck; Anil G Jegga; Abdullah M Ali; Haihong Guo; Amom R Meetei; Paul R Andreassen; Ferdinand Kappes; Lisa M Privette Vinnedge; Jeremy A Daniel; Ralph Scully; Lisa Wiesmüller; Susanne I Wells
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

9.  The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival.

Authors:  Kari E Hacker; Danielle E Bolland; Lijun Tan; Anjan K Saha; Yashar S Niknafs; David M Markovitz; Karen McLean
Journal:  Neoplasia       Date:  2018-11-06       Impact factor: 5.715

Review 10.  NUP214 in Leukemia: It's More than Transport.

Authors:  Adélia Mendes; Birthe Fahrenkrog
Journal:  Cells       Date:  2019-01-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.